Fate of the liver in the survivors of adult heart transplant for a failing Fontan circulation

J Heart Lung Transplant. 2022 Mar;41(3):283-286. doi: 10.1016/j.healun.2021.10.020. Epub 2021 Nov 11.

Abstract

The Fontan circulation has inherent long-term vulnerabilities such that adult Fontan patients now comprise the largest, most rapidly growing subgroup of adult congenital heart disease referred for transplant assessment. Almost all have Fontan Associated Liver Disease (FALD). There is an absence of mid to late hepatic outcome data after heart transplant alone. Therefore, we analyzed outcomes of survivors of heart only transplant in patients with failing Fontan circulation. Including all 10 of our adult Fontan patients surviving >1 year after isolated heart transplant, we report evolution of their clinical features, bloodwork, hemodynamic data, and liver ultrasound findings over a median of 4.7 years. Nonprogression of FALD, resolution of ascites and freedom from hepatocellular carcinoma in the mid-term highlight the outcomes in this selected group once normal cardiac output and venous pressures are established by heart transplant.

Keywords: Fontan associated liver disease; Fontan failure; adult congenital heart disease; heart transplantation.

MeSH terms

  • Adult
  • Female
  • Fontan Procedure*
  • Heart Defects, Congenital / surgery*
  • Heart Transplantation*
  • Humans
  • Liver Diseases / epidemiology*
  • Male
  • Middle Aged
  • Postoperative Complications / epidemiology*
  • Retrospective Studies
  • Treatment Failure
  • Treatment Outcome